EGFR and neoplasm: Notably, YTHDF2 functioned as a tumor suppressor in HCC by negatively modulating EGFR mRNA stability via its binding to the m6A site in the 3′-UTR of EGFR mRNA, in turn impairing the MEK/ERK pathway and consequently impeding the cell proliferation and growth [102].